Some doctors balk at inhaled insulin
(AP)


AP - Pfizer's stab at giving diabetics insulin without needles is getting more praise than prescriptions so far. Exubera, a powdered form inhaled through a special device, was introduced last year in a targeted launch to specialists, a debut analysts deemed disappointing. While doctors applaud Pfizer Inc.'s effort to find a new way to deliver insulin, some are concerned about the drug's long-term effects on the lungs, cost and insurance coverage.

Read more...